Researchers at the University of Cologne, University Hospital Cologne and the Max Planck Institute for Metabolism Research have developed a method that, for the first time, enables damage to individual cells to be precisely quantified. The method uses molecular markers—specifically gene expression—and enables detailed analysis of disease progression in individual tissue samples, such as a biopsy.